Stock Chart
CRMD
Type: SELL wallstreet
Strike: $15
Premium: $3.30
Expiry: Jan 15, 2027
Target: $15
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About CRMD - CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Key Statistics
More CRMD Analysis
This CRMD stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track CRMD's price movements with trendlines, gamma walls, and key support/resistance levels.